HistoryThis section has been translated automatically.
DefinitionThis section has been translated automatically.
You might also be interested in
EtiopathogenesisThis section has been translated automatically.
Unknown; discussed is a parathyroid hormone insufficiency with hypocalcaemia in pregnancy or surgical damage to the epithelial corpuscles. The pathogenetic significant influence of pregnancy becomes obvious, as healing usually occurs after pregnancy.
In individual cases a mutation of the IL36RN gene has been reported.
ManifestationThis section has been translated automatically.
By definition, the disease only occurs in pregnant women; age: 20-40 years; mainly in the 2nd half of pregnancy. A recurrence is possible with each further pregnancy.
A manifestation can also occur outside of the pregnancy.
LocalizationThis section has been translated automatically.
Clinical featuresThis section has been translated automatically.
Acute onset with severe impairment of the general condition, with pronounced feeling of illness, fever, chills, possibly diarrhoea.
On the integument bent exanthema with highly red, large erythema and plaques.
After a few days, disseminated or grouped, 0.1-0.2 cm large, white, bizarrely limited (not follicular) pustules develop on these flat lesions, initially single, later confluent to larger "pus lakes".
The formation of anular figures is possible. Healing with formation of inwardly directed collerette-like scaly margins.
Occurrence of erythroderma is possible.
Symptoms of hypocalcaemia may appear (low serum calcium, tetany, Chvostek's sign).
This very rare pregnancy dermatosis is associated with the highest risk for the pregnant woman compared to other pregnancy dermatoses.
LaboratoryThis section has been translated automatically.
Dysproteinemia; leucocytosis; neutrophilia; iron deficiency with anemia; decreased serum calcium; decreased Vit D3 levels; significantly accelerated SPA; CRP is elevated.
HistologyThis section has been translated automatically.
Differential diagnosisThis section has been translated automatically.
Complication(s)This section has been translated automatically.
TherapyThis section has been translated automatically.
External therapyThis section has been translated automatically.
Dehydrating measures. Application of ethanolic zinc oxide shaking mixture or dye brushes, e.g. with potassium permanganate (light pink) or methylrosanilinium chloride solution (gentian violet) to avoid secondary infections.
In addition, topical glucocorticoids such as 0.1% triamcinolone cream, 0.25% prednicarbate (e.g. Dermatop cream), 0.1% mometasone (e.g. Ecural fat cream) for improved healing of the skin as well as in case of highly inflammatory components.
Internal therapyThis section has been translated automatically.
In the foreground is the substitution of parathyroid hormone with dihydrotachysterol (eye drops 10) and calcium replacement according to blood level (for tetany: 20 ml calcium solution 10%).
Caution! Digitized patients!
For long-term treatment vitamin D and calcium p.o. The use of ACTH (e.g. Synacten) is also possible.
Close monitoring of hormone status, calcium level, iron and protein balance! Monitoring with regard to secondary infections!
Causitic messages exist about success with Secukinumab (Chhabra G et al. 2019).
Progression/forecastThis section has been translated automatically.
Note(s)This section has been translated automatically.
LiteratureThis section has been translated automatically.
- Chhabra G et al (2019) Impetigo herpetiformis responsive to secukinumab. Dermatol Ther 32:e13040.
- Chang SE (2003) Impetigo herpetiformis followed by generalized pustular psoriasis: more evidence of same disease entity. Int J Dermatol 42: 754-755
- Kaposi M (1887) Impetigo herpetiformis. Arch Dermatol Syphil 19: 273-296
- Renner R et al (2010) chronic inflammatory and autoimmune mediated dermatoses in pregnancy. dermatologist 61: 1021-1026
- Gao QQ et al (2013) Impetigo Herpetiformis during pregnancy: a case report and literature review. Dermatology 226: 35-40
- Soutou B et al (2015) Skin disease in pregnancy. Best Pract Res Clin Obstetr Gynaecol 29: 732-740
- Sugiura K et al (2014) IL36RN mutations underlie impetigo herpetiformis. J Invest Dermatol 134:2472-2474
- Weiseseel P et al. (2016) Pustular psoriasis. Dermatologist 67: 445-453
Incoming links (4)Impetigo herpetiformis hebra-kaposi; Impetigo (overview); Pregnancy dermatosis, atopic; Pustular psoriasis;
Outgoing links (11)Candidoses; Dermatitis herpetiformis; Gentian violet; Glucocorticosteroids; Glucorticosteroids topical; Potassium permanganate; Prednicarbate; Prednisolone; Pustular psoriasis; Pyoderma; ... Show all
Please ask your physician for a reliable diagnosis. This website is only meant as a reference.